{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:13:14Z","timestamp":1790172794724,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resuscitationjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Resuscitation"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.resuscitation.2020.10.030","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:29:51Z","timestamp":1603888191000},"page":"91-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety and benefit of Glycoprotein IIb\/IIIa inhibitors in out of hospital cardiac arrest patients treated with percutaneous coronary intervention"],"prefix":"10.1016","volume":"157","author":[{"given":"Fabien","family":"Picard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Sokoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Diefenbronn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driss","family":"Laghlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Seret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-8860","authenticated-orcid":false,"given":"Olivier","family":"Varenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resuscitation.2020.10.030_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.resuscitation.2015.07.018","article-title":"European Resuscitation Council and European Society of Intensive Care Medicine guidelines for post-resuscitation care 2015: section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015","volume":"95","author":"Nolan","year":"2015","journal-title":"Resuscitation"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcin.2017.09.011","article-title":"Should we perform an immediate coronary angiogram in all patients after cardiac arrest?: Insights from a large French registry","volume":"11","author":"Bougouin","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4244\/EIJV10I1A7","article-title":"Invasive coronary treatment strategies for out-of-hospital cardiac arrest: a consensus statement from the European association for percutaneous cardiovascular interventions (EAPCI)\/stent for life (SFL) groups","volume":"10","author":"Noc","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.resuscitation.2019.10.022","article-title":"The balance of thrombosis and hemorrhage in STEMI patients with or without associated cardiac arrest: an observational study","volume":"145","author":"Picard","year":"2019","journal-title":"Resuscitation"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.resuscitation.2016.06.031","article-title":"Safety of glycoprotein IIb\/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome","volume":"106","author":"Jim\u00e9nez-Br\u00edtez","year":"2016","journal-title":"Resuscitation"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0035","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0040","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0050","first-page":"28","article-title":"Microparticles and sudden cardiac death due to coronary occlusion. The TIDE (Thrombus and Inflammation in sudden DEath) study","volume":"4","author":"Empana","year":"2015","journal-title":"Eur Heart J: Acute Cardiovasc Care"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.resuscitation.2017.01.030","article-title":"Thrombus composition in sudden cardiac death from acute myocardial infarction","volume":"113","author":"Silvain","year":"2017","journal-title":"Resuscitation"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0060","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719893274","article-title":"Intravenous antiplatelet therapies (glycoprotein IIb\/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use","volume":"13","author":"Capodanno","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0065","first-page":"E204","article-title":"Glycoprotein IIb\/IIIa inhibitor use in patients with acute myocardial infarction undergoing PCI: insights from the TRANSLATE ACS study","volume":"93","author":"Ibrahim","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0039-1700546","article-title":"Efficacy and safety of glycoprotein IIb\/IIIa inhibitors on top of Ticagrelor in STEMI: a subanalysis of the ATLANTIC trial","volume":"120","author":"Tavenier","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2017.01.010","article-title":"Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes","volume":"186","author":"Ducrocq","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13613-018-0366-x","article-title":"Impaired aspirin-mediated platelet function inhibition in resuscitated patients with acute myocardial infarction treated with therapeutic hypothermia: a prospective, observational, non-randomized single-centre study","volume":"8","author":"Pr\u00fcller","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0085","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4244\/EIJY14M05_02","article-title":"Platelet reactivity in comatose survivors of cardiac arrest undergoing percutaneous coronary intervention and hypothermia","volume":"10","author":"Steblovnik","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pharmthera.2016.01.004","article-title":"Current status of data on cangrelor","volume":"159","author":"Qamar","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.resuscitation.2020.10.030_bib0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41569-018-0118-5","article-title":"Predictors of stent thrombosis and their implications for clinical practice","volume":"16","author":"Gori","year":"2019","journal-title":"Nat Rev Cardiol"}],"container-title":["Resuscitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300957220305384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300957220305384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:12:28Z","timestamp":1759547548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300957220305384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":19,"alternative-id":["S0300957220305384"],"URL":"https:\/\/doi.org\/10.1016\/j.resuscitation.2020.10.030","relation":{},"ISSN":["0300-9572"],"issn-type":[{"value":"0300-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and benefit of Glycoprotein IIb\/IIIa inhibitors in out of hospital cardiac arrest patients treated with percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Resuscitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resuscitation.2020.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}